Giorgia Gurioli - Concepedia

Author

Giorgia Gurioli

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ORCID

Also Known As

G. Gurioli, Giorgia Gurioli, Gurioli, Giorgia

113

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Istituti di Ricovero e Cura a Carattere Scientifico University College London Ospedale G.B. Morgagni - L.Pierantoni London Cancer

About

Giorgia Gurioli is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in urology, oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	85
2	Pathology	1	1	26
3	Pharmacology	1	1	32
4	Cancer Therapeutics	1	1	26
5	Molecular Oncology	1	1	26

Giorgia Gurioli

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Plasma <i>AR</i> and abiraterone-resistant prostate cancer Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Science Translational Medicine	2015	431
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani, Annals of Oncology	2017	263
Genome-wide plasma DNA methylation features of metastatic prostate cancer Anjui Wu, Paolo Cremaschi, Daniel Wetterskog, Journal of Clinical Investigation	2020	98
<i>GSTP1</i>Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications Filippo Martignano, Giorgia Gurioli, Samanta Salvi, Disease Markers	2016	95
Circulating <i>AR</i> copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer Samanta Salvi, Valentina Casadio, Vincenza Conteduca, Oncotarget	2016	74
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide Marzia Del Re, Vincenza Conteduca, Stefania Crucitta, Prostate Cancer and Prostatic Diseases	2021	55
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients Samanta Salvi, Giorgia Gurioli, Filippo Martignano, Disease Markers	2015	47
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer Vincenza Conteduca, Emanuela Scarpi, Samanta Salvi, Scientific Reports	2018	38
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer Vincenza Conteduca, Daniel Wetterskog, Emanuela Scarpi, British Journal of Cancer	2020	33
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer Vincenza Conteduca, Elena Castro, Daniel Wetterskog, European Journal of Cancer UrologyOncologyGenitourinary CancerMedicinePlasma Ar Status	2019	32

Page 1